(0.37%) 5 110.25 points
(0.77%) 38 677 points
(0.64%) 17 763 points
(0.34%) $79.22
(0.34%) $2.04
(-0.09%) $2 307.50
(-0.42%) $26.72
(0.96%) $971.80
(-0.19%) $0.930
(-0.79%) $10.90
(-0.18%) $0.796
(0.54%) $91.62
1.75% $ 18.58
@ $22.28
Emitido: 14 feb 2024 @ 13:20
Retorno: -16.61%
Señal anterior: feb 14 - 09:30
Señal anterior:
Retorno: 1.83 %
Live Chart Being Loaded With Signals
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients...
Stats | |
---|---|
Volumen de hoy | 926 814 |
Volumen promedio | 1.94M |
Capitalización de mercado | 2.26B |
EPS | $0 ( 2024-02-22 ) |
Próxima fecha de ganancias | ( $-0.940 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.34 |
ATR14 | $0.0170 (0.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-30 | Krognes Steve E. | Sell | 154 | Restricted Stock Units |
2024-04-30 | Krognes Steve E. | Buy | 154 | Common Stock |
2024-04-15 | Tariq Musa | Sell | 249 | Restricted Stock Units |
2024-04-15 | Tariq Musa | Buy | 249 | Common Stock |
2024-04-15 | Saia John G. | Buy | 7 569 | Common Stock |
INSIDER POWER |
---|
-46.47 |
Last 99 transactions |
Buy: 862 724 | Sell: 2 348 187 |
Volumen Correlación
Guardant Health Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
TBLT | 0.956 |
IMBI | 0.95 |
MSEX | 0.946 |
RIDE | 0.941 |
EBIX | 0.938 |
MEIP | 0.937 |
FWRD | 0.935 |
AGRX | 0.934 |
ASLE | 0.933 |
ENNV | 0.932 |
10 Correlaciones Más Negativas | |
---|---|
SKYA | -0.951 |
ADAL | -0.95 |
CRZN | -0.947 |
LDHA | -0.943 |
MSDAU | -0.942 |
VLAT | -0.941 |
TBSAU | -0.94 |
TIOA | -0.939 |
HERA | -0.939 |
DXJS | -0.936 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Guardant Health Inc Correlación - Moneda/Commodity
Guardant Health Inc Finanzas
Annual | 2023 |
Ingresos: | $563.95M |
Beneficio Bruto: | $336.90M (59.74 %) |
EPS: | $-4.28 |
FY | 2023 |
Ingresos: | $563.95M |
Beneficio Bruto: | $336.90M (59.74 %) |
EPS: | $-4.28 |
FY | 2022 |
Ingresos: | $449.54M |
Beneficio Bruto: | $293.21M (65.23 %) |
EPS: | $-6.41 |
FY | 2021 |
Ingresos: | $373.65M |
Beneficio Bruto: | $250.74M (67.11 %) |
EPS: | $-4.00 |
Financial Reports:
No articles found.
Guardant Health Inc
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico